Literature DB >> 1590692

Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.

R Allendoerfer1, R R Yates, A J Marquis, D Loebenberg, M G Rinaldi, J R Graybill.   

Abstract

SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives. In this study, we compared the efficacy of 304 with that of 426 and 427 in murine models of cryptococcal and coccidioidal meningitis. On day 18 postinfection with Cryptococcus neoformans, controls showed 80% mortality. The 50% protective doses calculated at this day were 0.56 mg of 304 per kg of body weight, 23.5 mg of 426 per kg, and 0.11 mg of 427 per kg. Controls with coccidioidal meningitis all succumbed, and treated mice at the same time point showed 50% protective doses of 10.8 mg/kg for 304, 200 mg/kg for 426, and 2.1 mg/kg for 427. We conclude that isomer 427 is five times as potent, whereas 426 is 1/50th as potent as 304 in these experimental mycoses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590692      PMCID: PMC189266          DOI: 10.1128/AAC.36.1.217

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.

Authors:  J R Perfect; K A Wright; M M Hobbs; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 3.  Extrapulmonary Pneumocystis carinii infections.

Authors:  E E Telzak; R J Cote; J W Gold; S W Campbell; D Armstrong
Journal:  Rev Infect Dis       Date:  1990 May-Jun

4.  In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.

Authors:  T Tanio; K Ichise; T Nakajima; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).

Authors:  J R Graybill; S H Sun; J Ahrens
Journal:  J Med Vet Mycol       Date:  1986-04

6.  Itraconazole therapy for chronic coccidioidal meningitis.

Authors:  R M Tucker; D W Denning; B Dupont; D A Stevens
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

7.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

8.  Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.

Authors:  A M Stamm; R B Diasio; W E Dismukes; S Shadomy; G A Cloud; C A Bowles; G H Karam; A Espinel-Ingroff
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

9.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

10.  Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature.

Authors:  E Bouza; J S Dreyer; W L Hewitt; R D Meyer
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

View more
  3 in total

1.  In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.

Authors:  D Loebenberg; A Cacciapuoti; R Parmegiani; E L Moss; F Menzel; B Antonacci; C Norris; T Yarosh-Tomaine; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome.

Authors:  J S Hostetler; E Brummer; R L Coffman; D A Stevens
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 3.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.